4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-18-002466
President & CEO sold 114,677 shares at an average $1.17 ($134,067)
From the SEC's structured data for this filing
Trades in this filing
Mohan Pankaj · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-03 | Sale : show line 1 in the form | −52,108 | $1.18 | $61,487 | 7,119,122 | D |
| 2018-01-04 | Sale : show line 2 in the form | −62,569 | $1.16 | $72,580 | 7,056,553 | D |
| Open-market sales · 114,677 sh · avg $1.17 · $134,067 | ||||||
Loading xslF345X03/doc4.xml…